Olli M. Dufva

Helsinki, 00290, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

Journal: bioRxiv : the preprint server for biology

Published: April 27, 2026

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Journal: Cancer immunology research

Published: February 04, 2026

Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+ T cells with a disease-associated TCR signature.

Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+ T cells with a disease-associated TCR signature.

Journal: Science translational medicine

Published: February 26, 2025

Unlocking a genetic model of NK-cell transformation.

Unlocking a genetic model of NK-cell transformation.

Journal: Blood

Published: June 13, 2024

High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

Journal: Blood

Published: May 17, 2024

Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping.

Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping.

Journal: Nature immunology

Published: October 25, 2023

Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia.

Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia.

Journal: Cell reports. Medicine

Published: September 20, 2023

Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.

Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.

Journal: Blood cancer discovery

Published: September 13, 2023

Tracing back primed resistance in cancer via sister cells.

Tracing back primed resistance in cancer via sister cells.

Journal: Nature communications

Published: April 25, 2023

Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.

Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.

Journal: Leukemia

Published: March 31, 2023

Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers.

Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers.

Journal: Immunity

Published: October 31, 2022

Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.

Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.

Journal: The Journal of clinical investigation

Published: August 25, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026